treating adults treating kids

FDA Approves New ADHD Medication from KemPharm

March 5, 2021A new ADHD medication has gained approved from the U.S. Food and Drug Administration (FDA). KemPharm’s AZSTARYS™, a once-daily methylphenidate stimulant medication previously known as KP415, has been approved by for the treatment of attention deficit hyperactivity disorder (ADHD or ADD) in individuals aged six years and older.

The website is an aggregator of articles from open sources. The source is indicated at the beginning and at the end of the announcement. You can send a complaint on the article if you find it unreliable.

Related articles